计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| U138038-1mg |
1mg |
期货 ![]() |
|
| 英文别名 | BDBM17054 | NSC638850 | NSC-638850 | 7-Hydroxystaurosporine [WHO-DD] | KRX0601 | KRX-0601 | Dietilamina | Isocyanic acid ethyl ester | AKOS030230764 | Anesthenyl | (+)-UCN-01 | 1-Ethoxyethylene | Q27074035 | (2S,3R,4R,6R,18R)-18-hydroxy-3-methoxy-2-methyl |
|---|---|
| 规格或纯度 | Moligand™, ≥95%(HPLC) |
| 英文名称 | UCN-01 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 3 磷脂肌醇依赖性蛋白激酶 1 的抑制剂;检查点激酶 1 的抑制剂;检查点激酶 2 的抑制剂;细胞周期蛋白依赖性激酶 1 的抑制剂;糖原合酶激酶 3 beta 的抑制剂;LCK 原癌基因的抑制剂;Src 家族酪氨酸激酶;微管亲和性调节激酶 1 抑制剂; 丝裂原活化蛋白激酶 14 抑制剂; 蛋白激酶 A 抑制剂; 蛋白激酶 C alpha 抑制剂; 蛋白激酶 C beta 抑制剂; 蛋白激酶 C delta 抑制剂; 蛋白激酶 C epsilon 抑制剂; 蛋白激酶 C gamma 抑制剂 |
| 产品介绍 |
浓度 1mg/ml Description: Application: UCN 01 is a protein kinase C inhibitor which overrides ZEB1-induced chemoresistance in hepatocellular cancer in human. A cell-permeable Staurosporine derived anticancer agent that inhibits several protein kinases. |
| 纯度 | ≥95%(HPLC) |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | (2S,3R,4R,6R,18R)-18-hydroxy-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one |
| INCHI | 1S/C28H26N4O4/c1-28-25(35-3)15(29-2)12-18(36-28)31-16-10-6-4-8-13(16)19-21-22(27(34)30-26(21)33)20-14-9-5-7-11-17(14)32(28)24(20)23(19)31/h4-11,15,18,25,27,29,34H,12H2,1-3H3,(H,30,33)/t15-,18-,25-,27-,28+/m1/s1 |
| InChi Key | PBCZSGKMGDDXIJ-HQCWYSJUSA-N |
| Smiles | CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)C(NC6=O)O)NC)OC |
| Isomeric SMILES | C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)[C@H](NC6=O)O)NC)OC |
| PubChem CID | 72271 |
| 分子量 | 482.53 |
| 分子量 | 482.500 g/mol |
|---|---|
| XLogP3 | 2.700 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 5 |
| 可旋转键计数Rotatable Bond Count | 2 |
| 精确质量Exact Mass | 482.195 Da |
| 单同位素质量Monoisotopic Mass | 482.195 Da |
| 拓扑极表面积Topological Polar Surface Area | 89.700 Ų |
| 重原子数Heavy Atom Count | 36 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 935.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 5 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| WGK Germany | 3 |
|---|
| 1. Busby EC, Leistritz DF, Abraham RT, Karnitz LM, Sarkaria JN. (2000) The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1.. Cancer Res, 60 (8): (2108-12). [PMID:10786669] |
| 2. Sato S, Fujita N, Tsuruo T. (2002) Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine).. Oncogene, 21 (11): (1727-38). [PMID:11896604] |
| 3. Jiang X, Zhao B, Britton R, Lim LY, Leong D, Sanghera JS, Zhou BB, Piers E, Andersen RJ, Roberge M. (2004) Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide.. Mol Cancer Ther, 3 (10): (1221-7). [PMID:15486189] |
| 4. Reinhardt HC, Aslanian AS, Lees JA, Yaffe MB. (2007) p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.. Cancer Cell, 11 (2): (175-89). [PMID:17292828] |
| 5. Takahashi I, Kobayashi E, Asano K, Yoshida M, Nakano H. (1987) UCN-01, a selective inhibitor of protein kinase C from Streptomyces.. J Antibiot, 40 (12): (1782-4). [PMID:3429345] |
| 6. Seynaeve CM, Kazanietz MG, Blumberg PM, Sausville EA, Worland PJ. (1994) Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue.. Mol Pharmacol, 45 (6): (1207-14). [PMID:8022414] |